Darin Lippoldt Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Darin Lippoldt.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Darin Lippoldt. Darin Lippoldt is Chief Legal Officer in NEUROCRINE BIOSCIENCES INC ($NBIX) and SR. VP and General Counsel in Volcano Corp ($VOLC).
Latest Insider Trading Transactions of Darin Lippoldt
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 35.99 | 36,194 | 1,302,622 | 0 | |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 0.00 | 6,908 | 0 | 6,908 | |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 117.63 | 41,444 | 4,875,058 | 41,444 | |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 116.21 | 6,008 | 698,160 | 34,361 | 40.4 K to 34.4 K (-14.88 %) |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 35.99 | 6,008 | 216,228 | 40,369 | 34.4 K to 40.4 K (+17.48 %) |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 117.55 | 186 | 21,864 | 34,361 | 34.5 K to 34.4 K (-0.54 %) |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 35.99 | 186 | 6,694 | 34,547 | 34.4 K to 34.5 K (+0.54 %) |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 116.16 | 30,000 | 3,484,806 | 34,361 | 64.4 K to 34.4 K (-46.61 %) |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 35.99 | 30,000 | 1,079,700 | 64,361 | 34.4 K to 64.4 K (+87.31 %) |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 116.72 | 1,522 | 177,650 | 34,361 | 35.9 K to 34.4 K (-4.24 %) |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 116.74 | 1,198 | 139,859 | 32,991 | 34.2 K to 33 K (-3.50 %) |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 116.69 | 687 | 80,166 | 31,914 | 32.6 K to 31.9 K (-2.11 %) |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 114.05 | 605 | 69,003 | 30,627 | 31.2 K to 30.6 K (-1.94 %) |
| Nov 16 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 90.72 | 2,257 | 204,755 | 30,082 | 32.3 K to 30.1 K (-6.98 %) |
| Aug 07 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 118.87 | 2,257 | 268,297 | 28,051 | 30.3 K to 28.1 K (-7.45 %) |
| Jul 10 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 35.99 | 1,657 | 59,635 | 36,194 | |
| Jul 10 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 136.02 | 1,657 | 225,386 | 26,021 | 27.7 K to 26 K (-5.99 %) |
| Jul 10 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 35.99 | 1,657 | 59,635 | 27,678 | 26 K to 27.7 K (+6.37 %) |
| Jun 25 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 32.99 | 5,000 | 164,950 | 0 | |
| Jun 25 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 130.00 | 5,000 | 650,000 | 26,021 | 31 K to 26 K (-16.12 %) |
| Jun 25 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 32.99 | 5,000 | 164,950 | 31,021 | 26 K to 31 K (+19.22 %) |
| May 20 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 32.99 | 5,000 | 164,950 | 5,000 | |
| May 20 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 120.00 | 5,000 | 600,000 | 26,021 | 31 K to 26 K (-16.12 %) |
| May 20 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 32.99 | 5,000 | 164,950 | 31,021 | 26 K to 31 K (+19.22 %) |
| Apr 28 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 99.49 | 1,934 | 192,416 | 26,021 | 28 K to 26 K (-6.92 %) |
| Feb 11 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 103.32 | 1,522 | 157,247 | 24,124 | 25.6 K to 24.1 K (-5.93 %) |
| Feb 07 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 0.00 | 7,897 | 0 | 7,897 | |
| Feb 07 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 102.90 | 49,844 | 5,128,948 | 49,844 | |
| Feb 07 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 101.47 | 1,198 | 121,556 | 22,755 | 24 K to 22.8 K (-5.00 %) |
| Feb 07 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 103.15 | 605 | 62,407 | 21,678 | 22.3 K to 21.7 K (-2.72 %) |
| Feb 07 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 102.88 | 1,145 | 117,800 | 21,133 | 22.3 K to 21.1 K (-5.14 %) |
| Nov 13 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 32.99 | 3,375 | 111,341 | 10,000 | |
| Nov 13 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 32.99 | 6,625 | 218,559 | 0 | |
| Nov 13 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 110.02 | 3,375 | 371,307 | 20,103 | 23.5 K to 20.1 K (-14.38 %) |
| Nov 13 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 32.99 | 3,375 | 111,341 | 23,478 | 20.1 K to 23.5 K (+16.79 %) |
| Nov 13 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 110.00 | 6,625 | 728,750 | 20,103 | 26.7 K to 20.1 K (-24.79 %) |
| Nov 13 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 32.99 | 6,625 | 218,559 | 26,728 | 20.1 K to 26.7 K (+32.96 %) |
| Sep 05 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 32.99 | 6,736 | 222,221 | 6,625 | |
| Sep 05 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 100.00 | 6,736 | 673,600 | 20,103 | 26.8 K to 20.1 K (-25.10 %) |
| Sep 05 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 32.99 | 6,736 | 222,221 | 26,839 | 20.1 K to 26.8 K (+33.51 %) |
| Aug 27 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 32.99 | 1,600 | 52,784 | 13,361 | |
| Aug 27 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 32.99 | 1,664 | 54,895 | 14,961 | |
| Aug 27 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 100.00 | 1,600 | 160,000 | 19,961 | 21.6 K to 20 K (-7.42 %) |
| Aug 27 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 32.99 | 1,600 | 52,784 | 21,561 | 20 K to 21.6 K (+8.02 %) |
| Aug 27 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 100.09 | 1,664 | 166,555 | 19,961 | 21.6 K to 20 K (-7.69 %) |
| Aug 27 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 32.99 | 1,664 | 54,895 | 21,625 | 20 K to 21.6 K (+8.34 %) |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 18.15 | 15,831 | 287,333 | 0 | |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 92.13 | 15,831 | 1,458,569 | 19,961 | 35.8 K to 20 K (-44.23 %) |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 18.15 | 15,831 | 287,333 | 35,792 | 20 K to 35.8 K (+79.31 %) |
| Feb 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 0.00 | 11,567 | 0 | 11,567 | |
| Feb 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 81.05 | 62,506 | 5,066,111 | 62,506 | |
| Feb 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 83.52 | 791 | 66,063 | 19,646 | 20.4 K to 19.6 K (-3.87 %) |
| Feb 06 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 88.11 | 470 | 41,409 | 18,162 | 18.6 K to 18.2 K (-2.52 %) |
| Feb 06 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 88.08 | 755 | 66,501 | 17,482 | 18.2 K to 17.5 K (-4.14 %) |
| Mar 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 18.15 | 1,979 | 35,919 | 15,831 | |
| Mar 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 88.47 | 1,979 | 175,090 | 16,062 | 18 K to 16.1 K (-10.97 %) |
| Mar 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 18.15 | 1,979 | 35,919 | 18,041 | 16.1 K to 18 K (+12.32 %) |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 0.00 | 12,250 | 0 | 12,250 | |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 0.00 | 4,600 | 0 | 4,600 | |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 81.49 | 26,050 | 2,122,815 | 26,050 | |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 18.15 | 1,979 | 35,919 | 17,810 | |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Payment of Exercise | F | 82.48 | 787 | 64,912 | 16,062 | 16.8 K to 16.1 K (-4.67 %) |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 83.13 | 758 | 63,012 | 14,574 | 15.3 K to 14.6 K (-4.94 %) |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 83.11 | 1,979 | 164,482 | 13,157 | 15.1 K to 13.2 K (-13.07 %) |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 18.15 | 1,979 | 35,919 | 15,136 | 13.2 K to 15.1 K (+15.04 %) |
| Jan 04 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 18.15 | 1,979 | 35,919 | 19,789 | |
| Jan 04 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 79.36 | 1,979 | 157,053 | 13,157 | 15.1 K to 13.2 K (-13.07 %) |
| Jan 04 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 18.15 | 1,979 | 35,919 | 15,136 | 13.2 K to 15.1 K (+15.04 %) |
| Jan 02 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 18.15 | 15,237 | 276,552 | 21,768 | |
| Jan 02 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 75.00 | 15,237 | 1,142,775 | 13,157 | 28.4 K to 13.2 K (-53.66 %) |
| Jan 02 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 18.15 | 15,237 | 276,552 | 28,394 | 13.2 K to 28.4 K (+115.81 %) |
| Dec 11 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 18.15 | 2,955 | 53,633 | 37,005 | |
| Dec 11 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 75.00 | 2,955 | 221,625 | 13,157 | 16.1 K to 13.2 K (-18.34 %) |
| Dec 11 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 18.15 | 2,955 | 53,633 | 16,112 | 13.2 K to 16.1 K (+22.46 %) |
| Dec 06 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 18.15 | 6,279 | 113,964 | 39,960 | |
| Dec 06 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 75.04 | 6,279 | 471,160 | 13,157 | 19.4 K to 13.2 K (-32.31 %) |
| Dec 06 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 18.15 | 6,279 | 113,964 | 19,436 | 13.2 K to 19.4 K (+47.72 %) |
| Sep 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 18.15 | 100 | 1,815 | 56,139 | |
| Sep 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 60.00 | 100 | 6,000 | 13,157 | 13.3 K to 13.2 K (-0.75 %) |
| Sep 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 18.15 | 100 | 1,815 | 13,257 | 13.2 K to 13.3 K (+0.76 %) |
| Aug 14 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 18.15 | 5,000 | 90,750 | 56,239 | |
| Aug 14 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 55.00 | 5,000 | 275,000 | 13,157 | 18.2 K to 13.2 K (-27.54 %) |
| Aug 14 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 18.15 | 5,000 | 90,750 | 18,157 | 13.2 K to 18.2 K (+38.00 %) |
| May 23 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 18.15 | 10,000 | 181,500 | 61,239 | |
| May 23 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 53.27 | 10,000 | 532,700 | 13,157 | 23.2 K to 13.2 K (-43.18 %) |
| May 23 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 18.15 | 10,000 | 181,500 | 23,157 | 13.2 K to 23.2 K (+76.01 %) |
| Apr 13 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 51.23 | 204 | 10,451 | 13,157 | 13.4 K to 13.2 K (-1.53 %) |
| Apr 13 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 50.41 | 12,861 | 648,323 | 13,361 | 26.2 K to 13.4 K (-49.05 %) |
| Feb 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 0.00 | 9,100 | 0 | 9,100 | |
| Feb 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 43.24 | 68,400 | 2,957,616 | 68,400 | |
| Feb 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 44.62 | 132 | 5,890 | 1,222 | 1.4 K to 1.2 K (-9.75 %) |
| Feb 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 43.13 | 821 | 35,410 | 0 | 821 to 0 (-100.00 %) |
| Feb 09 2016 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 0.00 | 20,500 | 0 | 20,500 | |
| Feb 09 2016 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 35.99 | 41,200 | 1,482,788 | 41,200 | |
| Feb 09 2016 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | A | 0.00 | 8,700 | 0 | 8,700 | |
| Nov 10 2015 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 18.15 | 23,761 | 431,262 | 71,239 | |
| Nov 10 2015 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 52.92 | 23,761 | 1,257,432 | 0 | 23.8 K to 0 (-100.00 %) |
| Nov 10 2015 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 18.15 | 23,761 | 431,262 | 23,761 | 0 to 23.8 K |
| Feb 17 2012 | VOLC | Volcano Corp | Lippoldt Darin | SR. VP and General ... | Option Exercise | M | 0.00 | 700 | 0 | 2,100 | |
| Feb 17 2012 | VOLC | Volcano Corp | Lippoldt Darin | SR. VP and General ... | Sell | S | 28.07 | 296 | 8,309 | 404 | 700 to 404 (-42.29 %) |
| Feb 17 2012 | VOLC | Volcano Corp | Lippoldt Darin | SR. VP and General ... | Buy | M | 0.00 | 700 | 0 | 700 | 0 to 700 |
| Feb 17 2011 | VOLC | Volcano Corp | Lippoldt Darin | SR. VP and General ... | Option Exercise | A | 0.00 | 2,800 | 0 | 2,800 | |
| Feb 17 2011 | VOLC | Volcano Corp | Lippoldt Darin | SR. VP and General ... | Option Exercise | A | 27.47 | 6,700 | 184,049 | 6,700 |
Page: 1